bepridil has been researched along with Brain Thrombosis in 1 studies
Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lipsanen, A | 1 |
| Flunkert, S | 1 |
| Kuptsova, K | 1 |
| Hiltunen, M | 1 |
| Windisch, M | 1 |
| Hutter-Paier, B | 1 |
| Jolkkonen, J | 1 |
1 other study available for bepridil and Brain Thrombosis
| Article | Year |
|---|---|
Non-selective calcium channel blocker bepridil decreases secondary pathology in mice after photothrombotic cortical lesion.
Topics: Amyloid beta-Peptides; Animals; Bepridil; Brain Ischemia; Calcium Channel Blockers; Intracranial Thr | 2013 |